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ABSTRACT Two monocysteine mutants of cardiac muscle troponin C, cTnC(C35S) and cTnC(C84S), were genetically
generated and labeled with the fluorescent probe 2-[4'-(iodoacetamido)anilino]naphthalene-6-sulfonic acid (IAANS) at Cys-84
and Cys-35, respectively. Cys-84 is located on helix D in the regulatory N-domain, and Cys-35 is at the -y position of the
inactive 12-residue loop of site 1. These labeled mutants were studied by a variety of steady-state and time-resolved
fluorescence methods. In the absence of divalent cation, the fluorescence of the attached IAANS indicated an exposed
environment at Cys-35 and a relatively less-exposed environment at Cys-84. The binding of Ca2+ to the single regulatory site
elicited a large enhancement of the emission of IAANS attached to Cys-84, but only marginal fluorescence changes of the
probe at Cys-35. Upon reconstitution of the labeled cTnC mutants with troponin and troponin T to form the three-subunit
troponin, the fluorescence of IAANS-Cys-84 in apo-troponin was spectrally similar to that observed with the Ca2'-loaded
uncomplexed cTnC mutant. Only very moderate changes in the fluorescence of IAANS-Cys-84 were observed when the
regulatory site in reconstituted troponin was saturated. The exposed Cys-35 environment of the uncomplexed cTnC mutant
became considerably less exposed and less polar when the mutant was incorporated into apo-troponin. In contrast to the
Cys-84 site, saturation of the regulatory site 11 by Ca2+ in reconstituted troponin resulted in a reversal of the environment of
the Cys-35 site toward a more exposed and more polar environment. These results indicated involvement of the inactive loop
I in the Ca2+ trigger mechanism in cardiac muscle. The fluorescence of IAANS at both Cys-84 and Cys-35 was sensitive to
phosphorylation of cTnl in reconstituted troponin, and the sensitivity was observed with both apo-troponin and Ca2+-loaded
troponin.
INTRODUCTION
Troponin C (TnC) is the Ca2'-binding protein of the thin
filament of muscle and has a regulatory role in vertebrate
skeletal and cardiac muscle. Ca2'-induced conformational
changes in TnC are believed to be transmitted via the
linkage between TnC and TnI (troponin I) within the three-
subunit troponin complex to activate actomyosin ATPase
and switch on muscle contraction (Cheung et al., 1987). The
crystal structures of TnC from skeletal muscle of turkey
(Herzberg and James, 1988) and chicken (Stayshur et al.,
1988) reveal a dumbbell-shaped molecule with two globular
domains connected by a long central a-helix. Each domain
contains two metal ion binding sites, designated as sites I
and II in the N-domain, and sites III and IV in the C-
domain. Sites III and IV have a relatively high affinity for
Ca2+ (Ka -107 M-) and also bind Mg2+ competitively
(Ka _103 M-1), whereas sites I and II have a lower Ca2+
affinity and are specific for Ca2+ (Ka - 105 M- 1). Current
evidence indicates that the C-domain in which the two
binding sites are occupied by Ca2+/Mg2+ throughout the
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contraction/relaxation cycle plays a structural role, and the
N-domain plays a regulatory role.
Cardiac TnC (cTnC) differs from skeletal TnC in that site
I in the cardiac isoform is inactive in chelating Ca2+ due to
several amino acid substitutions in critical positions in the
12-residue Ca2+-binding loop (van Eerd and Takahashi,
1976). Although the three-dimensional structure of cTnC
has not been determined, it is reasonable to assume, on the
basis of sequence homology and similarities in physiologic
functions, that its structure is similar to that of skeletal TnC.
Reversible Ca2+ binding to site II is believed to induce
conformational changes in the N-domain, and these changes
appear to modulate the TnC-TnI linkage in the regulatory
mechanisms. The precise nature of these conformational
changes is still obscure. A useful biophysical approach to
delineate Ca2+-induced conformational changes in TnC is
to use extrinsic fluorescent probes attached to different
regions of the protein. Cardiac TnC contains two cysteine
residues; Cys-35, located at the nonfunctional Ca2+-binding
loop I, and Cys-84, located at the C-terminal end of helix D,
where the TnC-TnI interaction occurs. In previous studies,
both Cys-35 and Cys-84 in native cTnC were modified with
the fluorescent probe: 2-[4'-(iodoacetamido)anilino]naph-
thalene-6-sulfonic acid (IAANS), and the fluorescence of
the probe was used to study the binding of Ca2+ to site II in
isolated cTnC and in troponin reconstituted with the
IAANS-labeled cardiac TnC (Johnson et al., 1980; Robert-
son et al., 1982; El-Saleh and Solaro, 1987), and the equi-
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librium interaction between cTnC and cTnI (cardiac tropo-
nin I) (Liao et al., 1994). In these previous studies, a 1.8- to
2-fold increase in the fluorescence of cTnCAANS was ob-
served when Ca2+ bound to site II in isolated cTnC. It has
been assumed that the observed large increase in fluores-
cence is due predominantly to the probe attached to Cys-84,
because Cys-84 is strategically located in the amino-termi-
nal domain, and a probe linked to this position might sense
Ca2+-activated conformational changes involving specific
helices. Studies of monocysteine cTnC mutants labeled at
either Cys-84 or Cys-35 have confirmed this notion (Zhang
et al., 1992; Dong et al., 1996). Cardiac troponin reconsti-
tuted with native cTnC doubly labeled with IAANS at both
Cys-84 and Cys-35 showed a 15-20% decrease in fluores-
cence upon binding Ca2+ at site II (Johnson et al., 1980;
Robertson et al., 1982; Liao et al., 1994). It is not entirely
clear whether the observed fluorescence decrease in the
troponin complex is due to the probe attached to both
Cys-84 and Cys-35 or due predominantly to the probe
attached to one or the other cysteine. The present work was
initiated to characterize the fluorescence of IAANS individ-
ually linked to Cys-35 and Cys-84 and to study structural
alterations in the regions of the two cysteine residues that
are accompanied by Ca2+ activation in cardiac troponin.
This was accomplished by using monocysteine mutants of
cTnC, each labeled with IAANS at its single sulfhydryl
group, and reconstituted with the other two cardiac troponin
subunits. IAANS is an environmentally sensitive probe. The
change in the fluorescence parameters of the probe attached
to cTnC can be used to reveal changes in local conforma-
tion, particularly environmental changes in the vicinity of
the attached probe. This information is used to gain insight
into possible involvement of different segments of cTnC in
calcium activation.
MATERIALS AND METHODS
Preparation of troponin subunits
Cardiac muscle troponin was extracted from an ether powder that was
prepared from the left ventricles of fresh bovine hearts (Potter, 1982).
Troponin subunits were initially separated on a CM-Sephadex C-50-120
column in the presence of 6 M urea, 50mM Tris at pH 8.0, and 1 mM DTT.
Fractions of crude cTnC, cTnI, and cTnT (cardiac troponin T), were pooled
and subsequently purified, separately, on a DEAE-Sephadex A-50 column
in the presence of 6 M urea. cTnC was eluted with a gradient from 0 to 0.5
M KCI at pH 7.0, while cTnI and cTnT were eluted at pH 8.0 with a
gradient from 0 to 0.5 KCI. The purity of each protein was monitored by
NaDodSO4 polyacrylamide gel electrophoresis. The purified proteins were
lyophilized in the presence of 0.3 M KCI, 0.5 mM EGTA, 0.5 mM DTT,
20 mM imidazole at pH 7.2, and stored at -20°C.
Preparation and characterization of cardiac
TnC mutants
Mutants of cTnC from rat cardiac muscle were obtained using the expres-
sion vector pET-24a(+) and overexpressed in Escherichia coli BL21(DE3)
as previously described (Dong et al., 1996). The ability of the mutants to
support Ca2" regulation of tension development was monitored using
chemically skinned reconstituted rabbit skeletal muscle fibers (Martyn and
Gordon, 1988). Mutant cTnC(C84S) and cTnC(C35S) were found to have
good functional properties (Dong et al., 1996).
Preparation of labeled cTnC mutants
Mutants cTnC(C35S) and cTnC(C84S) were first dialyzed against 0.5 mM
DTT in a solution containing 0.2 M KCI, 30 mM MOPS at pH 7.0,
followed by a second dialysis in which DTT was omitted. The sulfhydryl-
reduced protein was reacted with a two to three-fold molar excess of
IAANS in the presence of 6 M urea at 4°C for 10 h. The reaction was
terminated with a three to fivefold excess of DTT, and the solution was
exhaustively dialyzed against 6 M urea, 30 mM MOPS at pH 7.0, 0.2 M
KCI, and 2 mM EGTA at 40C, to remove unreacted fluorophore and DTT.
A further dialysis against the same buffer without urea was repeated three
times. The concentration of the labeled protein was determined with either
a turbidimetric tannin micromethod (Mejbaum-Katzenellenbogen and Do-
bryszcka, 1959) or the Bradford method (Bradford, 1976), and the amount
of label covalently attached to the protein was determined by absorbance,
using a molar extinction coefficient of 24,900 M-lcm-' (Johnson et al.,
1980). The labeling ratio was >0.9 mol fluorophore/mol protein for the
two monocysteine mutants, and 1.8-2.0 for native cTnC.
Reconstitution of troponin
Binary complex formed between IAANS-labeled mutant cTnC and native
cTnI and ternary complex of labeled cTnC with native cTnI and cTnT were
prepared by incubating the labeled cTnC with a large excess of cTnI or
cTnI plus cTnT in a buffer containing 30 mM MOPS, pH 7.2, 1 mM DTT,
50 mM Ca2+, and 6 M urea. After a 30-min incubation at room tempera-
ture, the solutions were first dialyzed at 40C against a buffer containing 30
mM MOPS at pH 7.2, 1 mM DTT, 50 mM Ca2', 3 M urea, and 1 M KCI.
The urea and KCI concentrations were then reduced stepwise by changing
to the following dialysis buffers containing no urea and a decreasing level
of KCI: a) 1.0 M KCI, b) 0.7 M KCI, c) 0.5 M KCI, d) 0.3 M KC1, and e)
0.1 M KCI. Uncomplexed cTnI and cTnT were precipitated during dialysis
and were removed by centrifugation. The solutions containing the com-
plexes were dialyzed against a final buffer containing 30 mM MOPS at pH
7.2, 1 mM DTT, 1 mM EGTA, and 0.3 M KCI (basic buffer).
Phosphorylation of cTnI
cTnI was phosphorylated at pH 7.0 in 50 mM KH2PO4, 0.5 mM EGTA, 0.5
mM DTT, and 125 units catalytic subunit of protein kinase A/mg cTnI. The
reaction was started by adding ATP to a final concentration of 0.5 mM,
followed by incubation at 300C for 20 min. The solution was then dialyzed
exhaustively at 4°C against the basic buffer.
Steady-state fluorescence measurements
Steady-state fluorescence measurements were carried out at 20 ± 0.1 °C on
an SLM 8000C spectrofluorometer. The band pass of both the excitation
and emission monochromators was set at 3 nm, and the measurements were
made in the ratio mode. Emission spectra were corrected for variations of
the detector system with wavelengths. Quantum yields of IAANS were
determined by the comparative method (Parker and Rees, 1960), using
quinine sulfate in 0.1 N H2SO4 as the standard (0.52 at A,, = 365 nm and
0.47 at Aex = 325 nm) (Melhuish, 1964). Absorption spectra were recorded
on a Beckman DU-40 spectrophotometer at room temperature.
Quenching of IAANS fluorescence intensity was measured by adding
aliquots of an 8-M acrylamide to the sample. When necessary, a correction
was made for inner filter effects. The emission was measured at 459 nm for
nonphosphorylated sample and at 467 nm for phosphorylated samples with
325 nm excitation. The quenching data were analyzed by the Stern-Volmer
equation. The dynamic bimolecular quenching constant (kq) was calculated
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from kq = Ksv/(T), where KSV is the Stern-Volmer dynamic quenching
constant and (T) is the mean fluorescence lifetime.
A standard calcium solution (Orion) was used in titration experiments.
EGTA was used to control the level of free calcium, and free calcium
concentrations were calculated as described previously (Dong et al., 1996),
using known stability constants of the chelator for proton and cations.
Time-resolved fluorescence measurements
Fluorescence intensity decay of IAANS covalently linked to mutant cTnC
was measured in the basic buffer at 20°C on a PRA single photon-counting
system (Model 3000) with a DCM [4-(dicyanomethylene)-2-methyl-6-(p-
dimethylaminostyryl)-4H-pyran] dye laser synchronously pumped by a
mode-locked argon ion laser (Model 171, Spectra-Physics). The mode-
locker operated at 41 MHz, and the cavity-dumped laser was set at 4 MHz
and provided a train of light pulses with a 15-ps full width at half-
maximum (FWHM). The output from the dye laser was frequency-doubled
to 325 nm by an angle-tuned KDP crystal (Model 390, Spectra-Physics) to
generate uv/ps laser pulses with tunable frequency from 315 to 335 nm.
The laser intensity was attenuated by neutral density filters such that the
emitted photon counting rate was reduced to <3 kHz to avoid photon
pile-up. The PM tube was a Hamamatsu R955, and the photon counting
system had a response time of -500 ps in FWHM. For lifetime measure-
ments, the excitation polarizer was set at the vertical direction and the
emission polarizer was oriented at the magic angle (54.70 from the hori-
zontal). The emission was detected at a right angle to the excitation beam.
The emission wavelengths were selected with a 4-nm band pass mono-
chromator (Instrument SA, Inc.) or a Ditric 3-cavity 334-nm interference
filter. Decay curves were collected into 1024 channels of a multichannel
analyzer at a resolution of 20-30 ps/channel until 2 X 104 photons were
collected in the peak channel. The decay data were fitted to a sum of
exponential terms using a least-squares reconvolution procedure as previ-
ously described (Liao et al., 1992)
F(t) =1ajexp(-t/Tj)
where Ti are the lifetimes and a, are the associated fractional amplitudes.
The goodness-of-fit was evaluated by the reduced chi-squares ratio (XR),
the weighted residuals, and the Durbin-Watson parameter (D-W). In the
present experiments, 0.9 < X2R < 1.2, and D-W > 1.8.
Reagents and chemicals
IAANS was obtained from Molecular Probes (Eugene, OR) and used
without further purification. It was dissolved in dimethylformamide at
concentrations of 10-15 mM and stored in the dark at either 4 or -20°C.
The catalytic subunit of protein kinase A from beef heart was obtained
from Sigma (St. Louis, MO). All other chemicals were of reagent grade.
RESULTS
This study was carried out to investigate, under different
ionic conditions, the fluorescence properties of IAANS at-
tached to Cys-35 of cTnC(C84S) and Cys-84 of
cTnC(C35S) reconstituted with cTnI and cTnT. These spec-
tral properties were used to deduce the nature of conforma-
tional changes induced by Ca2+ binding to the regulatory
domain. For comparison, the fluorescence properties of
native cTnC doubly labeled with IAANS were also exam-
ined in parallel experiments.
Steady-state fluorescence
Fig. 1 shows the emission spectra of IAANS in doubly
labeled native cTnC (A), singly labeled mutant at Cys-84
(B), and singly labeled mutant at Cys-35 (C). In the absence
of divalent cations, the fluorescence intensity of IAANS
attached to Cys-35 (Fig. 1 C, curve 1) was threefold lower
than that of the probe attached to Cys-84 (Fig. 1 B, curve 1)
or attached to both Cys-35 and Cys-84 (Fig. 1 A, curve 1).
The spectral peaks of these three spectra were within 1-2
nm of each other (Table 1). In the presence of Mg2+, the
fluorescence intensity of each labeled protein decreased by
10-15% with no detectable spectral shift. When both Mg2+
and Ca2+ were present, the intensity of the probe attached to
both Cys-35 and Cys-84 (Fig. 1 A) or to Cys-84 (Fig. 1 B)
increased by a factor of -2.0 and 1.6, respectively. These
increases were accompanied by a blue spectral shift of 5 nm.
These spectral changes are consistent with the observations
reported previously (Johnson et al., 1980; Zhang et al.,
1992; Dong et al., 1996). IAANS linked to Cys-35 re-
sponded to the addition of Ca2+ with little or no changes in
intensity and spectral shift (Fig. 1 C). The fluorescence
quantum yields and emission maxima determined for these
and other reconstituted troponin systems are summarized in
Table 1.
Fig. 2 shows a family of fluorescence emission spectra
that were obtained from binary complexes of IAANS-la-
beled native cTnC and the two labeled cTnC mutants, each
reconstituted with cTnI. For all three complexes, the inten-
sity observed in the absence of divalent cations increased
significantly when compared with that of the isolated la-
beled cTnC (Fig. 1). A 1.5-fold increase was observed for
native cTnC with an 8-nm blue spectral-shift (curve I of
Fig. 2 A versus curve I in Fig. 1 A). Similar changes were
observed for the binary complex formed between the cTnC
mutant labeled at Cys-84 and cTnI (Fig. 2 B, curve 1). With
0.8 220.8~
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FIGURE 1 Fluorescence emission spectra of native cTnC labeled with
IAANS at Cys-35 and Cys-84 (A), mutant cTnC(C35S) labeled at Cys-84
(B), and mutant cTnC(C84S) labeled at Cys-35 (C). Curve 1: EGTA; curve
2: Mg2+; curve 3: Mg2+ + Ca2+. The peak intensities of the spectra were
normalized to the peak intensity of curve 1 (B). All samples contained 2
,uM labeled protein, 2 mM EGTA, 0.3 M KCI, and 30 mM MOPS at pH
7.2, and were excited at 325 nm.
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TABLE I Fluorescence properties of cTnC and cTnC mutants and their complexes with cTnl and cTnT
in EGTA in Mg2l in Ca21
Sample Aem (nm) QreI (T) (ns) Aem (nm) Qrel (T) (ns) Aem (nm) Qrel (T) (ns)
cTnC(Cys-84)IAANs 459 1.00 4.32 459 0.95 4.33 456 1.54 6.23
Binary complex 451 1.58 5.57 451 1.48 5.56 453 1.61 5.66
Temary complex 451 1.63 5.64 451 1.56 5.42 455 1.56 5.52
p-binary complex 454 1.21 5.21 454 1.21 5.08 457 1.68 5.44
p-ternary complex 455 1.36 5.11 455 1.31 4.93 453 1.58 5.31
cTnC(Cys-35)IAANS 460 0.35 4.06 460 0.29 4.10 461 0.29 4.01
Binary complex 449 1.00 5.24 450 0.88 4.95 458 0.3 3.61
Ternary complex 451 0.97 5.25 452 0.87 5.09 460 0.34 3.23
p-binary complex 449 0.94 5.08 452 0.88 5.00 458 0.55 4.14
p-ternary complex 449 0.91 5.09 451 0.92 5.19 457 0.59 4.28
cTnC(Cys-84)IAANS is a cTnC mutant labeled with IAANS at Cys-84, and cTnC(Cys-35)IAANS is cTnC mutant labeled with IAANS at Cys-35. The binary
complex under each group of samples is the complex formed between the IAANS-labeled cTnC species in that group and native cTnI, and ternary complex
is the complex formed with the labeled cTnC and native cTnI and cTnT. p-binary complex is the binary complex in which the cTnI is phosphorylated by
PKA, and p-ternary complex is the complex in which the cTnI subunit is phosphorylated. The quantum yield of cTnC(Cys-84)AANS was 0.086, and the
relative quantum yields (QreI) of all samples were normalized to this value. Experimental errors of the quantum yield were <10% at all conditions. (T) is
the intensity-weighted mean lifetime and is given by (T) = 72ajT'r/7,ajTj. The experimental errors of (T) were <6.0%. The experimental errors of the emission
maximum were ±1 nm at all conditions. Measurements were made at 20°C in the basic buffer. EGTA concentration was 1 mM, Mg2+ concentration was
3 mM, and Ca2+ concentration was 2 mM.
the complex from the cTnC mutant singly labeled at Cys-35
(Fig. 2 C, curve 1), the increase in intensity was a factor of
3 with a 10-nm blue shift of the emission maximum. The
considerably larger increase in the intensity of IAANS at
Cys-35 of cTnC induced by complexation with cTnI would
suggest a substantial alteration of the immediate environ-
ment of Cys-35 in the binary complex.
In the presence of Mg2+, the intensity of the two binary
complexes of cTnI with the labeled cTnC mutants decreased
by 5-10% with no spectral shift (Fig. 2, B and C, curve 2).
The presence of both Mg2+ and Ca2+ decreased the inten-
sity of the complex obtained with doubly labeled native
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FIGURE 2 Fluorescence emission spectra of binary complexes of
IAANS-labeled cTnC with native cTnI. (A) native cTnC doubly labeled at
Cys-35 and Cys-84, (B) mutant cTnC(C35S) singly labeled at Cys-84, and
(C) mutant cTnC(C84S) singly labeled at Cys-35. Curve 1: EGTA; curve
2: Mg2+; curve 3: Mg2+ + Ca2+. The peak intensities of the spectra were
normalized to that of uncomplexed, mutant cTnC(C35S) labeled at Cys-84
determined in the presence of EGTA (Fig. 2 B, curve 1). This normaliza-
tion makes possible direct comparison of the emission of all six samples
shown in both Figs. 1 and 2. Samples contained 2 ,uM of labeled protein.
Other conditions were the same as for Fig. 1.
3), in agreement with early reports (Johnson et al., 1980:
Robertson et al., 1982). This large Ca2+ effect was not
observed with the binary complex formed between the
cTnC mutant labeled at Cys-84 and cTnI (Fig. 2 B, curves
2 and 3). However, the cTnC mutant singly labeled at
Cys-35 complexed to cTnI responded to Ca2+ with a 2.3-
fold decrease in the IAANS intensity and a 9-nm red spec-
tral shift (Fig. 2 C, curve 3). These results suggest that the
fluorescence properties of IAANS linked to Cys-35 were
largely responsible for the Ca2+-induced spectral changes
observed with native cTnC doubly labeled with IAANS at
both Cys-35 and Cys-84. IAANS attached to Cys-35 of
cTnC sensed only Ca2+-induced environmental changes
that occurred in the binary complex with cTnI. This is in
contrast to the probe located at Cys-84, which was sensitive
to Ca2+-induced conformational changes in cTnC (Fig. 1
B), but not to changes that occurred in the binary complex.
Similar fluorescence studies were also carried out with
ternary complexes of IAANS-labeled native cTnC and the
two IAANS-labeled cTnC mutants with cTnI and cTnT
(data not shown). Essentially identical results were obtained
as for the corresponding binary complexes. These results are
summarized in Table 1.
Also listed in Table 1 are the steady-state fluorescence
properties of the binary and ternary complexes of the three
labeled species of cTnC reconstituted with cTnI phosphor-
ylated by protein kinase A. In the absence of divalent
cations or in the presence of Mg2+, the phosphorylation of
cTnI generally had little or no effect on the apparent spectral
properties of the probe attached to both cysteine residues in
the complexes. In the presence of Mg2+, the probe at
Cys-84 detected small environmental changes due to the
cTnI phosphorylation in both the binary and ternary com-
plexes. However, IAANS attached to Cys-35 appeared in-
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FIGURE 3 Ca21 titration of mutant cTnC(C84S) singly labeled with
LAANS at Cys-35 and complexed with native nonphosphorylated cTnI
(circles) and phosphorylated cTnI (triangles). The titration was monitored
by the change in the fluorescence of the probe (465 nm) with 325 nm
excitation, and was carried out in the presence of EGTA (open symbols)
and EGTA + Mg2+ (closed symbols). The fractional change in fluores-
cence is given by (F - FO)/(Fm - FO), where F is the intensity observed
at a given Ca2+ concentration, Fo is the intensity in the absence of Ca2',
and Fm is the intensity observed at a saturating level of Ca2 .
the fluorescence of IAANS attached to both Cys-35 and
Cys-84 increased by -35% in the binary complex contain-
ing the phosphorylated cTnI, but the intensity was essen-
tially unaltered in the ternary phosphorylated complex. This
sensitivity observed with the binary phosphorylated com-
plex appeared to be due to the probe at Cys-35, as the
fluorescence of IAANS linked to Cys-35 increased by 40
and 70% in the binary and ternary complexes, respectively,
after cTnI was phosphorylated.
Ca2+ titration of reconstituted troponin
A set of typical fluorescence titration curves of Ca2+ bind-
ing to the cTnC mutant labeled at Cys-35 and reconstituted
with nonphosphorylated and phosphorylated cTnI are
shown in Fig. 3. For the complex reconstituted with non-
phosphorylated cTnI, the half-maximum increase in fluo-
rescence change occurred at pCa 6.54, with a Hill coeffi-
cient of 1.5, corresponding to an apparent association
constant of 3.47 X 106 M-1. This value decreased to 8.03 X
105 M-1 in the complex reconstituted with the phosphory-
lated cTnI, corresponding to pCa 5.91 with a Hill coefficient
of 1.5. This decrease in the association constant of Ca2+ to
cTnC is very similar to the values previously reported with
cTnC doubly labeled at both Cys-84 and Cys-35, (Robert-
son et al., 1982), and indicates that IAANS attached at
Cys-35 of cTnC can sense Ca2+ binding to the regulatory
binding site II of cTnC in the binary complex. The apparent
Ca2+ binding constants for different systems are summa-
rized in Table 2.
Fluorescence intensity decay
The intensity decays of all IAANS-labeled cTnCs and their
binary or ternary complexes with other troponin subunits
followed a triexponential decay law with two major com-
ponents, in the ranges of 2-3 and 0.5-1 ns, and a minor long
component in the range of 6-7 ns (data not shown). The
origin of these three lifetimes were not clear at the present
time. The weighted mean lifetimes for the systems studied
are summarized in Table 1. These mean lifetimes were used
to calculate the bimolecular dynamic quenching constants.
Isolated native cTnCLAANs and mutant cTnC labeled at
Cys-84 had mean lifetimes of 4.7 and 4.3 ns, respectively.
Mg2+ had little effects on these mean lifetimes, but
Ca2+ binding to the regulatory site increased the mean
lifetimes to -6 ns. This Ca2+-induced increase in mean
lifetime was due to conformational changes in the Cys-84
region and resulted from a significant reduction of nonra-
diative processes due to internal quenching in the apo state
(Dong and Cheung, 1996). The observed mean lifetime of
IAANS attached to Cys-35 was shorter (-4.0 ns) than that
observed in the other two proteins, and was insensitive to
the presence of either Mg2+ or Ca2+. These properties are
in accord with the steady-state spectral results.
Upon reconstitution with cTnI (binary complex) In the
absence of divalent cations, the mean lifetimes ofIAANS in
native cTnC and the mutants increased by - 1 ns to 5.3-5.6
ns. No further changes were observed with fully reconsti-
tuted ternary complexes. The increase in lifetime observed
TABLE 2 Binding constants of IAANS-labeled cTnC and
cTnC mutants and their complexes with cTnI and cTnT
for Ca2+
K X 10-5, M-1
Sample in EGTA in Mg2+
cTnC(Cys-35,Cys-84)IAANs 4.3 ± 0.6 (1.4) 4.3 ± 0.6 (1.4)
Binary complex 27.8 ± 3.1 (1.5) 29.8 ± 3.5 (1.3)
Ternary complex 28.7 ± 3.0 (1.4) 26.7 ± 3.0 (1.4)
p-binary complex 9.0 ± 0.8 (1.3) 8.9 ± 0.9 (1.3)
p-ternary complex 8.8 ± 0.7 (1.4) 8.9 ± 0.8 (1.3)
cTnC(Cys-84)L,ANs 4.7 ± 0.5 (1.6) 6.0 ± 0.7 (1.7)
cTnC(Cys-35)IAANS
Binary complex 34.7 ± 3.2 (1.5) 33.6 ± 3.4 (1.5)
Ternary complex 33.2 ± 3.6 (1.5) 32.0 ± 2.8 (1.6)
p-binary complex 8.0 ± 0.7 (1.3) 8.2 ± 0.5 (1.3)
p-ternary complex 8.1 ± 0.6 (1.3) 8.3 ± 0.8 (1.4)
Notations for samples are the same as given for Table 1. The binding
constants were obtained from titration curves similar to those shown in Fig.
3, and the curves were analyzed by nonlinear least-squares fits as previ-
ously described (Dong et al., 1996). The numbers in parentheses are the
Hill coefficient from the least-squares fits. The experimental errors for the
Hill coefficient were <0.2. The measurements were made in the basic
buffer. EGTA concentration was 1 mM, and Mg2+ concentration was 3
mM.
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with apo binary complexes suggested that interaction be-
tween cTnC and cTnI altered the environment of the probe
at both Cys-84 and Cys-35. Addition of Mg2+ or Ca2+ had
little effect on the mean lifetime of IAANS attached to
Cys-84. However, the presence of Mg2+ + Ca2+ decreased
this mean lifetime to 3.3-3.6 ns for both the binary and
ternary complexes reconstituted with cTnC labeled at Cys-
35. This Ca2+-induced change in the mean lifetime was
consistent with the observed fluorescence quantum yield
changes (Table 1).
Generally, the binary or ternary complexes of cTnC re-
constituted with the phosphorylated cTnI increased the
mean lifetime of IAANS, but the increase was not as much
as that observed with nonphosphorylated cTnI. The life-
times were insensitive to the presence of Mg2+, but varied
with the presence of Ca2+ (Table 1). Unlike the complexes
reconstituted with nonphosphorylated cTnI, Ca2+ binding
to the regulatory site II of the mutant labeled at Cys-84
reconstituted with the phosphorylated cTnI increased the
mean lifetime by 8%, consistent with the steady-state data.
Ca2+ binding to site II of the mutant labeled at Cys-35
reconstituted with phosphorylated cTnI decreased the mean
lifetime by 5-10%, as compared with a 30-35% decrease
observed with complexes reconstituted with nonphosphory-
lated cTnI (Table 1).
Fluorescence quenching
To estimate the accessibility of solvent to residue Cys-84
and Cys-35 in cTnC and to acquire information on the
environment of IAANS attached to these two residues, the
fluorescence of IAANS attached to these residues was stud-
ied in the presence of acrylamide. The Stern-Volmer plots
for native cTnC and the two cTnC mutants, each labeled
with IAANS, were essentially linear (data not shown), re-
gardless of whether the labeled proteins were uncomplexed
or complexed with the other subunits. Phosphorylation of
cTnI did not affect the apparent linearity of the Stern-
Volmer plots for the binary or ternary complexes. The
bimolecular dynamic quenching constants (kq) derived from
the data are listed in Table 3. In the absence of added cations,
the values of kq for IAANS attached to Cys-84 of the cTnC
mutant in the binary and ternary complexes were reduced by
12-15% when compared with the value for the uncomplexed
cTnC. The phosphorylation of cTnI had no effect on kq for the
binary complex, but a small reduction (14%) for the ternary
complex. The effect of added Mg2+ on the quenching constant
was very small for both complexes, but the presence of both
Mg2+ and Ca2+ substantially reduced kq (33-24%) in the
binary and ternary complexes. The phosphorylation of cTnI in
these complexes further reduced kq by 23-35%. These results
would suggest considerable Ca2+-induced shielding of IAANS
linked to Cys-84 in the reconstituted apo-troponin. This shield-
ing was further increased when the regulatory site ofcTnC was
saturated by Ca2+.
The solvent accessibility of Cys-35-IAANS was substan-
TABLE 3 Fluorescence quenching constant for IAANS-
labeled cTnC and cTnC mutants, and their complexes formed
with cTnl and cTnT
kq X 10-8,M- S-
Sample in EGTA in Mg2+ in Ca21
cTnC(Cys-84)IAANS 2.85 + 0.31 3.27 ± 0.28 4.27 ± 0.37
Binary complex 2.51 ± 0.23 2.59 ± 0.28 2.84 ± 0.19
Ternary complex 2.43 ± 0.21 2.79 ± 0.32 3.25 ± 0.22
p-binary complex 2.51 + 0.25 2.32 ± 0.18 2.21 ± 0.20
p-ternary complex 2.09 ± 0.18 2.27 ± 0.24 2.11 ± 0.18
cTnC(Cys-35)IAANS 4.11 ± 0.33 4.17 ± 0.42 5.04 ± 0.47
Binary complex 1.60 + 0.20 1.85 ± 0.23 3.08 ± 0.32
Ternary complex 1.49 + 0.17 1.45 ± 0.11 3.28 ± 0.25
p-binary complex 1.98 ± 0.19 2.30 ± 0.17 3.29 ± 0.23
p-ternary complex 2.07 ± 0.14 2.54 ± 0.19 3.22 ± 0.29
See Table 1 for sample notations and conditions.
conditions, indicating IAANS linked to Cys-35 to be more
exposed than the same probe attached to Cys-84. The
shielding of Cys-35-IAANS in the binary and ternary com-
plexes, however, was considerably larger than Cys-84-
IAANS in the same apo complexes or in the presence of
Mg2+. When the ionic condition was changed from Mg2+ to
Mg2+ + Ca2 , the value of kq increased by a factor of 1.7
and 2.3 for the binary and ternary complexes, respectively.
This large increased exposure was in contrast to the small
increased exposure (1.10-1.16) observed for Cys-84-
IAANS. Phosphorylation of cTnl generally increased kq for
the binary and ternary complexes in the absence or presence
of divalent cations, although the combined effect of Mg2+
and Ca2+ was negligible.
DISCUSSION
Cardiac muscle troponin C has two cysteine residues at
positions 35 and 84. The sulfhydryl groups of these residues
are readily alkylated by IAANS, and the doubly labeled
cTnC has been extensively used to determine the Ca2+
sensitivity of myofibrillar ATPase and force development in
skinned muscle fibers. Because the two residues are located
in different regions within the regulatory N-domain, IAANS
chemically linked to the two side chains must have different
fluorescence properties. The fluorescence observed with the
doubly labeled cTnC preparation must reflect the properties
of two different local environments. This composite fluo-
rescence cannot be used to follow Ca2+-induced structural
perturbations in the two regions. We have used two mono-
cysteine cTnC mutants, each labeled with IAANS at its
single sulfhydryl group, to examine changes in the local
environments of individual cysteine residues without poten-
tial interference from the probe signal of the other residue,
and to assess possible involvement of the two regions of the
N-domain in subunit interactions in reconstituted cardiac
muscle troponin.
The fluorescence properties of IAANS attached to
Cys-84 in isolated cTnC mutant responds to the binding of
Ca2+ to the single regulatory site with a large increase
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tially higher than that of Cys-84-IAANS, regardless of ionic
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(62%) in quantum yield (Qrel from 0.92 to 1.49), a 3-nm
blue spectral shift (459-456 nm), and a 2-ns increase in the
mean lifetime (4.3-6.2 ns). Similar changes were previ-
ously observed with native cTnC selectively labeled with
IAANS at Cys-84, and those changes have been interpreted
in terms of a more "open" N-domain conformation in which
internal quenching of IAANS-Cys-84 (located on helix D)
by side chains surrounding Cys-84 is reduced (Dong and
Cheung, 1996). Such an open conformation is consistent
with computer models that predict Ca2+-induced move-
ments of helices B and C away from helices N, A, and D
(Herzberg et al., 1986; Ovaska and Taskinen, 1991). These
movements may lead to the exposure of a short hydrophobic
stretch on helix B for Ca2+-induced interaction with a target
protein which, presumably, is troponin I. This interaction is
believed to be the trigger of the contractile cycle. In the
binary and ternary complexes reconstituted with cTnC mu-
tant labeled at Cys-84 and the other troponin subunits, Qrel
remains relatively constant in the range of 1.4-1.6, and the
mean lifetime is in the range of 5.4-5.7 ns, regardless of
ionic conditions. The emission spectra of the complexes
show a red-shift of 2-4 nm (451-455 nm) when the regu-
latory site is filled. These results indicate that a) the envi-
ronment of Cys-84 in reconstituted apo-troponin may be
very similar to that of Cys-84 in isolated cTnC saturated
with Ca2+, and b) the binding of Ca2+ to the regulatory site
of cTnC in troponin does not significantly alter the Cys-84
environment. While it is not surprising that the Cys-84
region has different conformations dependent upon whether
cTnC is isolated or in association with the other two tropo-
nin subunits, it should be noted that, even in the absence of
bound activator Ca2+ at the regulatory site, the conforma-
tion of the Cys-84 region in the complexes is spectrally very
similar to that of isolated cTnC, in which the regulatory site
is occupied. It is not known to what extent the orientations
of helices B and C in cardiac troponin may be different from
the orientations in uncomplexed cTnC, but the orientations
in the two states are likely different so as to bring about the
observed enhancement of the radiative processes of IAANS
attached to Cys-84 in the complexes. The present results
raise the possibility that Ca2+-induced rearrangements of
the N-domain helices of cTnC in the troponin complex may
be less extensive than as suggested by computer models on
the basis of homologous EF-hand motifs of the C-domain
and N-domain of the troponin C crystal structure.
The fluorescence properties of IAANS-Cys-35 in the
cTnC mutant clearly indicate a highly exposed environ-
ment. These properties are little affected by Ca2+ binding to
the regulatory site of the mutant, but are significantly
changed when the mutant is reconstituted into apo-troponin.
These fluorescence changes reflect the interaction between
cTnC and cTnI and alteration of the local conformation of
the Cys-35 region of the cTnC in troponin. These confor-
mational changes result in a depressed nonradiative process
of the probe. Upon binding Ca2+ at the regulatory site, this
new conformation in the apo troponin appears to be re-
tory site is occupied by Ca2+, as shown by an almost
complete reversal of the quantum yield and a significant
reduction in the lifetime. In this Ca2+-loaded state of tro-
ponin, the fluorescence of Cys-35-IAANS is highly
quenched when compared with that in the apo state. This
quenching results from a combination of a) a more polar
environment (9-10 nm red-shift), b) enhanced nonradiative
processes (a 2.5-fold decrease in quantum yield and a 2.6-
fold decrease in lifetime), and c) an increased exposure to
solvent collision (a 2-fold increase in kq). Cys-35 is located
at the -y coordinate of the 12-residue inactive Ca2+ bind-
ing loop of site I. IAANS attached to Cys-35 senses the
Ca2+-induced conformational change only in the presence
of cTnI, but not when the cTnC is isolated, whereas the
same probe attached to Cys-84 senses the conformational
changes in the isolated cTnC. Thus, the inactive loop I may
be involved in the Ca2+-dependent cTnC-cTnI interaction.
The present work with a monocysteine cTnC mutant labeled
at Cys-35 has provided evidence that a segment of the
inactive loop, if not the entire loop, responds to Ca2+
activation and strongly suggests participation of the inactive
loop in the trigger mechanism. Using chimeric TnC in
which the N-terminal 41 amino acids are of the cardiac type,
Gulati et al. (1992) showed that cardiac-type site I and
cardiac-type N-helix are essential for expression of the
cardiac phenotype.
In a similar chimeric TnC in which the inactive Ca2+
binding loop I was activated to chelate Ca2+ by genetic
modification, the cardiac-type Sr2+ sensitivity was found to
transform into the skeletal-type (Gulati and Rao, 1994).
Taken together, the present results and those of previous
studies strongly suggest that flexible loop I, in which the
side chains are not coordinated to a metal ion, may be
essential as part of the trigger mechanism in cardiac muscle.
Inasmuch as the helix-loop-helix segment of site I deviates
from the typical EF-hand motif (Herzberg and James,
1988), and as a typical EF-hand motif is formed only upon
chelating Ca2+, it is also possible that an EF-hand at site I
may prevent the N-terminal segment to participate in trig-
gering the expression of the cardiac phenotype. The avail-
able information does not delineate these possibilities.
With monocysteine mutants of cTnC, we have used the
environmental sensitive extrinsic fluorescent reagent
IAANS to probe the local conformations of Cys-84 and
Cys-35 of cTnC complexed with cTnI and reconstituted into
the three-subunit cardiac troponin. Within the troponin
complex, the Cys-84 region of helix D senses a relatively
open conformation that may be similar to the open confor-
mation of Ca2+-loaded uncomplexed cTnC. Saturation of
the single regulatory Ca2+ site does not appear to lead to a
significant change in the Cys-84 environment. This is in
contrast to Ca2+-induced changes observed with isolated
cTnC. Spectroscopic evidence has been obtained that shows
involvement of the Cys-35 region of the native, inactive
Ca2+ binding loop of site I in Ca2+ activation. This finding
suggests that a flexible loop may dictate participation of
versed back toward that of isolated cTnC when the regula-
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cardiac-type inactive site I in the activation mechanism.
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